{"Clinical Trial ID": "NCT02104895", "Intervention": ["INTERVENTION 1:", "\u2022 Whole Breast Irradiation (WBI)", "- Conventional whole breast irradiation (WBI)", "Integer Breast Irradiation (WBI): Conventional Whole Breast Irradiation (WBI)", "INTERVENTION 2:", "Partial breast irritation (APBI)", "- Acceleration of partial breast irradiation (APBI)", "- Acceleration of partial breast irradiation (APBI): Acceleration of partial breast irradiation (APBI) by modulated intensity radiotherapy (IMRT)"], "Eligibility": ["Incorporation criteria:", "Age at presentation > 40 years", "Tumour size < 25 mm", "Large excision or quadrantectomy with clear margins (>5 mm)", "\u2022 Clips placed in a tumour bed", "Informed and comprehensive patient consent", "- Exclusion criteria:", "Cardiac dysfunction", "Forced expiratory volume in 1 second (FEV1) <1 L/m", "\u2022 An extensive intraductal carcinoma", "Multifocal cancer", "Psychiatric problems", "Recurrent breast cancer"], "Results": ["Performance measures:", "Recurrence of ipsilateral breast tumours", "We defined local relapse (real recurrence) as the recurrence of breast cancer in the index quadrant and ipsilateral breast tumours as any new breast cancer diagnosed in other quadrants of the same breast. The sum of local relapses and new ipsilateral breast tumours was defined as the recurrence of ipsilateral breast tumours (IBTR).", "Calendar: 5 years", "Results 1:", "Title of the arm/group: Total breast irritation (WBI)", "Description of the arm/group: conventional whole breast irradiation (WBI)", "Integer Breast Irradiation (WBI): Conventional Whole Breast Irradiation (WBI)", "Total number of participants analysed: 260", "Type of measurement: Number", "Unit of measure: percentage of participants 1.4", "Results 2:", "Title of the arm/group: Partial breast irritation (APBI)", "Description of the arm/group: accelerated partial breast irradiation (APBI)", "- Acceleration of partial breast irradiation (APBI): Acceleration of partial breast irradiation (APBI) by modulated intensity radiotherapy (IMRT)", "Total number of participants analysed: 260", "Type of measurement: Number", "Unit of measure: percentage of participants 1.5"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/260 (0.00 per cent)", "Adverse Events 2:", "Total: 0/246 (0.00 per cent)"]}